Page 13 - Pharma Plc News Today

Nanoform and Herantis partner to look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules Nanoform Inside information December 17, 2020 at 7:15 p.m. Finnish time Nanoform and Herantis partner to look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative drug development company, today announced that they have signed a l...

Share this article Share this article ResearchAndMarkets.coms offering. The report gives insights into the transformational microbiome landscape. It is a rigorous assessment of the industry trends supported by detailed segmentation across publications, grants, clinical trials, and startup funding activity. The dataset behind the report is based on real world evidence that will drive actionable business insights. Follow trends over the years captured across publications, grants, clinical trial...